Skip to main content
. 2023 Aug;16(8):1038–1052. doi: 10.1016/j.jcmg.2023.02.019

Figure 5.

Figure 5

Kaplan-Meier Curves Demonstrating the Prognostic Effect of the Change in Multiorgan ECVs in Response to Treatment at 6 Months, Followed by a Univariable Cox Proportional Hazards Regression Analysis

(A) Kaplan-Meier curve comparing survival in patients with myocardial regression, a stable myocardial ECV, and myocardial progression at 6 months. (B) Kaplan-Meier curve comparing survival in patients with liver regression, a stable liver ECV and liver progression at 6 months. (C) Kaplan-Meier curve comparing survival in patients with spleen regression, a stable spleen ECV and spleen progression at 6 months. Abbreviation as in Figure 1.